Hugh Grant
Hugh Grant's purchase track record
Hugh Grant has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/25/2022 | FCX | $501K | -31.7% | -24.6% | -11.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
RBC Lowers Linde Price Target to $549 Amid Earnings Preview. RBC Capital has maintained its Outperform rating on Linde but lowered its price target to $549. This move comes as investors prepare for the company's upcoming quarterly earnings report. The stock is currently trading near its 52-week high, with an average analyst target of $544.15 suggesting limited upside from current levels.
Transaction History
| FCX | ▲ Buy | Grant | 482 | $34K | 10/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 536 | $34K | 7/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 574 | $34K | 4/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 664 | $34K | 1/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 860 | $34K | 10/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 778 | $34K | 7/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 924 | $35K | 4/1/2025 | View on chart |
| LIN | ▲ Buy | Option Exercise | 483 | $0 | 3/11/2025 | View on chart |
| FCX | ▲ Buy | Grant | 853 | $32K | 1/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 651 | $32K | 10/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 668 | $32K | 7/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 717 | $34K | 4/1/2024 | View on chart |
| LIN | ▲ Buy | Option Exercise | 599 | $0 | 3/11/2024 | View on chart |
| FCX | ▲ Buy | Grant | 734 | $31K | 1/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 838 | $31K | 10/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 781 | $31K | 7/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 763 | $31K | 4/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 822 | $31K | 1/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 1,143 | $31K | 10/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 1,068 | $31K | 7/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| FCX | ▲ Buy | Open Market | 12,300 | $501K | 4/25/2022 | View on chart |
| FCX | ▲ Buy | Grant | 628 | $31K | 4/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 748 | $31K | 1/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 2,100 | $0 | 12/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.